These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 16530841)

  • 1. High-valent nonheme iron-oxo species in biomimetic oxidations.
    Shan X; Que L
    J Inorg Biochem; 2006 Apr; 100(4):421-33. PubMed ID: 16530841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-valent iron(IV)-oxo complexes of heme and non-heme ligands in oxygenation reactions.
    Nam W
    Acc Chem Res; 2007 Jul; 40(7):522-31. PubMed ID: 17469792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomimetic hydrocarbon oxidation catalyzed by nonheme iron(III) complexes with peracids: evidence for an Fe(V)=O species.
    Lee SH; Han JH; Kwak H; Lee SJ; Lee EY; Kim HJ; Lee JH; Bae C; Lee SN; Kim Y; Kim C
    Chemistry; 2007; 13(33):9393-8. PubMed ID: 17685379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spectroscopy and electronic structures of mono- and binuclear high-valent non-heme iron-oxo systems.
    Decker A; Clay MD; Solomon EI
    J Inorg Biochem; 2006 Apr; 100(4):697-706. PubMed ID: 16510189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomimetic aryl hydroxylation derived from alkyl hydroperoxide at a nonheme iron center. Evidence for an Fe(IV)=O oxidant.
    Jensen MP; Lange SJ; Mehn MP; Que EL; Que L
    J Am Chem Soc; 2003 Feb; 125(8):2113-28. PubMed ID: 12590539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuning reactivity and mechanism in oxidation reactions by mononuclear nonheme iron(IV)-oxo complexes.
    Nam W; Lee YM; Fukuzumi S
    Acc Chem Res; 2014 Apr; 47(4):1146-54. PubMed ID: 24524675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxygen activation by nonheme iron(II) complexes: alpha-keto carboxylate versus carboxylate.
    Mehn MP; Fujisawa K; Hegg EL; Que L
    J Am Chem Soc; 2003 Jul; 125(26):7828-42. PubMed ID: 12823001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic mononuclear nonheme iron-oxygen intermediates.
    Nam W
    Acc Chem Res; 2015 Aug; 48(8):2415-23. PubMed ID: 26203519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in substrate hydroxylation reactions by heme and nonheme iron(IV)-oxo oxidants give correlations between intrinsic properties of the oxidant with barrier height.
    de Visser SP
    J Am Chem Soc; 2010 Jan; 132(3):1087-97. PubMed ID: 20041691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural insights into nonheme alkylperoxoiron(III) and oxoiron(IV) intermediates by X-ray absorption spectroscopy.
    Rohde JU; Torelli S; Shan X; Lim MH; Klinker EJ; Kaizer J; Chen K; Nam W; Que L
    J Am Chem Soc; 2004 Dec; 126(51):16750-61. PubMed ID: 15612713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative N-dealkylation reactions by oxoiron(IV) complexes of nonheme and heme ligands.
    Nehru K; Seo MS; Kim J; Nam W
    Inorg Chem; 2007 Jan; 46(1):293-8. PubMed ID: 17198439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dioxygen activation and catalytic aerobic oxidation by a mononuclear nonheme iron(II) complex.
    Kim SO; Sastri CV; Seo MS; Kim J; Nam W
    J Am Chem Soc; 2005 Mar; 127(12):4178-9. PubMed ID: 15783193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dioxygen activation at non-heme iron: insights from rapid kinetic studies.
    Korendovych IV; Kryatov SV; Rybak-Akimova EV
    Acc Chem Res; 2007 Jul; 40(7):510-21. PubMed ID: 17521158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetic studies of reactions of iron(IV)-oxo porphyrin radical cations with organic reductants.
    Pan Z; Zhang R; Newcomb M
    J Inorg Biochem; 2006 Apr; 100(4):524-32. PubMed ID: 16500709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-valent iron in chemical and biological oxidations.
    Groves JT
    J Inorg Biochem; 2006 Apr; 100(4):434-47. PubMed ID: 16516297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidizing intermediates from the sterically hindered iron salen complexes related to the oxygen activation by nonheme iron enzymes.
    Kurahashi T; Kobayashi Y; Nagatomo S; Tosha T; Kitagawa T; Fujii H
    Inorg Chem; 2005 Oct; 44(22):8156-66. PubMed ID: 16241166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the ruthenium analogue of compound I of cytochrome p450 an efficient oxidant? A theoretical investigation of the methane hydroxylation reaction.
    Sharma PK; De Visser SP; Ogliaro F; Shaik S
    J Am Chem Soc; 2003 Feb; 125(8):2291-300. PubMed ID: 12590559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactivities of mononuclear non-heme iron intermediates including evidence that iron(III)-hydroperoxo species is a sluggish oxidant.
    Park MJ; Lee J; Suh Y; Kim J; Nam W
    J Am Chem Soc; 2006 Mar; 128(8):2630-4. PubMed ID: 16492048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First-principle computation of zero-field splittings: application to a high valent Fe(IV)-oxo model of nonheme iron proteins.
    Aquino F; Rodriguez JH
    J Chem Phys; 2005 Nov; 123(20):204902. PubMed ID: 16351312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Theoretical studies of enzyme mechanisms involving high-valent iron intermediates.
    Bassan A; Blomberg MR; Borowski T; Siegbahn PE
    J Inorg Biochem; 2006 Apr; 100(4):727-43. PubMed ID: 16513176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.